Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Novartis
Ocellaris Pharma, Inc.
Bolt Biotherapeutics, Inc.
AbbVie
ImmuneSensor Therapeutics Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
Pfizer
Numab Therapeutics AG
NuCana plc
NRG Oncology
Turnstone Biologics, Corp.
Incyte Corporation
Emory University
Sotio Biotech Inc.
Novartis
Pfizer
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
Pfizer
Hoffmann-La Roche
Pfizer
ADC Therapeutics S.A.
Pfizer
Ikena Oncology
HiberCell, Inc.
University of Florida
Novartis
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
Genmab
4D pharma plc
Duke University
Genocea Biosciences, Inc.
TC Biopharm
MacroGenics
Incyte Corporation
Eli Lilly and Company
Cambridge University Hospitals NHS Foundation Trust
Seagen Inc.
Yale University
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Western Regional Medical Center